|
High $0.01 |
Low $0.01 |
Trades 6 |
Turnover $9,683 |
Volume 1,383,303 |
| 30 June 2023 at 3:17pm | ||||
|
Market Cap (5-Jun) $3,677,244 (1,574th) |
Close (30-Jun) $0.007 |
Volume (30-Jun) 1,383,303 |
Shortsold (6-Feb) 60,198 (0.02%) (486th) |
|
52w High $0.018 |
52w Low $0.003 |
P/E - |
EPS 0 |
RGS released this announcement to the ASX on 9 February 2021, 9:03. The announcement is marked as price sensitive, and is 2 page(s) in length and 146.19kb in size.
You can view all announcements from RGS and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RGS | |
|---|---|
| Ceasing to be a substantial holder | 15 June 2023, 12:45 |
| Change in substantial holding | 1 May 2023, 8:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 11:28 |
| Regeneus to be granted new patent to target pain in Japan | 9 February 2021, 9:03 |
| Response to ASX Appendix 4C Query | 5 February 2021, 9:08 |
| Clarification on Quarterly Activity Report and Appendix 4C | 5 February 2021, 8:17 |
| Appendix 4C - Quarterly Report | 29 January 2021, 9:06 |
You must be logged in to post a reply.
Regeneus Ltd 